AdSana
Overview
Adsana has developed an effective and affordable Cancer Infusion Therapy that has shown to kill cancer cells and cancer stem cells in dogs and in humans. The Adsana Team intends to establish Treatment Centers to deliver a new low cost, highly effective tr
Features
STO Details
Pre-sale
- Pre-sale start date Jun 01, 2019
- Pre-sale end date Jul 31, 2019
- Pre-sale token supply 100,000,000
Token Sale
- STO start date Sep 01, 2019
- STO end date Nov 30, 2019
- STO token supply 250,000,000
- Soft cap TBA
- Hard cap size $42,000,000
Token details
- Ticker SANA
- Type ERC20
- Additional Token Emission No
- Accepted Currencies USD, BTC, ETH
- Token distribution —
Legal
- Country Limitations —
- Registration Country United States
- Registration Year 2017
Rating Review and Analytics
- Investment Rating —
- Traction Low
- Risk Score —
AdSana Contacts
Ended 1875 days before $42,000,000
- Start STO Sep 01, 2019
- End STO Nov 30, 2019
- Funding type —
- Token SANA
- Price $0.20
- Minimum investment —
- Product Type Digital Asset
- KYC Yes
- Whitepaper View
STOs that might interest you
- Status TBA
- Traction Low
- Risk Score —
- Registration Year —
- Status Ended 2209 days before
- Traction Low
- Risk Score —
- Registration Year —
- Status Ended 2028 days before
- Traction Low
- Risk Score —
- Registration Year —